154 related articles for article (PubMed ID: 15459016)
1. PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.
Crowder C; Dahle Ø; Davis RE; Gabrielsen OS; Rudikoff S
Blood; 2005 Feb; 105(3):1280-7. PubMed ID: 15459016
[TBL] [Abstract][Full Text] [Related]
2. IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53.
Herzer K; Hofmann TG; Teufel A; Schimanski CC; Moehler M; Kanzler S; Schulze-Bergkamen H; Galle PR
Cancer Res; 2009 Feb; 69(3):855-62. PubMed ID: 19141642
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
[TBL] [Abstract][Full Text] [Related]
4. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Toomey NL; Deyev VV; Wood C; Boise LH; Scott D; Liu LH; Cabral L; Podack ER; Barber GN; Harrington WJ
Oncogene; 2001 Oct; 20(48):7029-40. PubMed ID: 11704827
[TBL] [Abstract][Full Text] [Related]
5. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
6. Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
Reu FJ; Leaman DW; Maitra RR; Bae SI; Cherkassky L; Fox MW; Rempinski DR; Beaulieu N; MacLeod AR; Borden EC
Cancer Res; 2006 Mar; 66(5):2785-93. PubMed ID: 16510600
[TBL] [Abstract][Full Text] [Related]
7. The promyelocytic leukemia protein represses A20-mediated transcription.
Wu WS; Xu ZX; Chang KS
J Biol Chem; 2002 Aug; 277(35):31734-9. PubMed ID: 12080044
[TBL] [Abstract][Full Text] [Related]
8. The key role of PML in IFN-α induced cellular senescence of human mesenchymal stromal cells.
Fu S; Wei J; Wang G; Wang B; Wang Y; Lai X; Huang H
Int J Oncol; 2015 Jan; 46(1):351-9. PubMed ID: 25354534
[TBL] [Abstract][Full Text] [Related]
9. Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase.
Shin J; Park B; Cho S; Lee S; Kim Y; Lee SO; Cho K; Lee S; Jin BS; Ahn JH; Choi EJ; Ahn K
J Biol Chem; 2004 Sep; 279(39):40994-1003. PubMed ID: 15273249
[TBL] [Abstract][Full Text] [Related]
10. The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage.
Salomoni P; Bernardi R; Bergmann S; Changou A; Tuttle S; Pandolfi PP
Blood; 2005 May; 105(9):3686-90. PubMed ID: 15626733
[TBL] [Abstract][Full Text] [Related]
11. PML is essential for multiple apoptotic pathways.
Wang ZG; Ruggero D; Ronchetti S; Zhong S; Gaboli M; Rivi R; Pandolfi PP
Nat Genet; 1998 Nov; 20(3):266-72. PubMed ID: 9806545
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα).
Cheng X; Liu Y; Chu H; Kao HY
J Biol Chem; 2012 Jul; 287(28):23356-67. PubMed ID: 22589541
[TBL] [Abstract][Full Text] [Related]
13. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
14. PML induces a novel caspase-independent death process.
Quignon F; De Bels F; Koken M; Feunteun J; Ameisen JC; de Thé H
Nat Genet; 1998 Nov; 20(3):259-65. PubMed ID: 9806544
[TBL] [Abstract][Full Text] [Related]
15. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
[TBL] [Abstract][Full Text] [Related]
16. EVI1 abrogates interferon-alpha response by selectively blocking PML induction.
Buonamici S; Li D; Mikhail FM; Sassano A; Platanias LC; Colamonici O; Anastasi J; Nucifora G
J Biol Chem; 2005 Jan; 280(1):428-36. PubMed ID: 15519999
[TBL] [Abstract][Full Text] [Related]
17. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
18. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.
Uno K; Inukai T; Kayagaki N; Goi K; Sato H; Nemoto A; Takahashi K; Kagami K; Yamaguchi N; Yagita H; Okumura K; Koyama-Okazaki T; Suzuki T; Sugita K; Nakazawa S
Blood; 2003 May; 101(9):3658-67. PubMed ID: 12506034
[TBL] [Abstract][Full Text] [Related]
19. PML-II regulates ERK and AKT signal activation and IFNα-induced cell death.
Meng X; Chen Y; Macip S; Leppard K
Cell Commun Signal; 2021 Jul; 19(1):70. PubMed ID: 34215258
[TBL] [Abstract][Full Text] [Related]
20. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
